Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia.
Avendaño-Solá C, Ramos-Martínez A, Muñez-Rubio E, Ruiz-Antorán B, Malo de Molina R, Torres F, Fernández-Cruz A, Calderón-Parra J, Payares-Herrera C, Díaz de Santiago A, Romera-Martínez I, Pintos I, Lora-Tamayo J, Mancheño-Losa M, Paciello ML, Martínez-González AL, Vidán-Estévez J, Nuñez-Orantos MJ, Saez-Serrano MI, Porras-Leal ML, Jarilla-Fernández MC, Villares P, de Oteyza JP, Ramos-Garrido A, Blanco L, Madrigal-Sánchez ME, Rubio-Batllés M, Velasco-Iglesias A, Paño-Pardo JR, Moreno-Chulilla JA, Muñiz-Díaz E, Casas-Flecha I, Pérez-Olmeda M, García-Pérez J, Alcamí J, Bueno JL, Duarte RF; ConPlas-19 Study Group. Avendaño-Solá C, et al. J Clin Invest. 2021 Oct 15;131(20):e152740. doi: 10.1172/JCI152740. J Clin Invest. 2021. PMID: 34473652 Free PMC article. Clinical Trial.
Sequential oral antibiotic in uncomplicated Staphylococcus aureus bacteraemia: a propensity-matched cohort analysis.
Diego-Yagüe I, Mora-Vargas A, Vázquez-Comendador JM, Santamarina-Alcantud B, Fernández-Cruz A, Múñez-Rubio E, Gutiérrez-Villanueva A, Sanchez-Romero I, Moreno-Torres V, Ramos-Martínez A, Calderón-Parra J. Diego-Yagüe I, et al. Clin Microbiol Infect. 2023 Jun;29(6):744-750. doi: 10.1016/j.cmi.2023.02.001. Epub 2023 Feb 10. Clin Microbiol Infect. 2023. PMID: 36773773
Trends in epidemiology, surgical management, and prognosis of infective endocarditis during the XXI century in Spain: A population-based nationwide study.
Calderón-Parra J, Gutiérrez-Villanueva A, Yagüe-Diego I, Cobo M, Domínguez F, Forteza A, Ana FC, Muñez-Rubio E, Moreno-Torres V, Ramos-Martínez A. Calderón-Parra J, et al. J Infect Public Health. 2024 May;17(5):881-888. doi: 10.1016/j.jiph.2024.03.011. Epub 2024 Mar 13. J Infect Public Health. 2024. PMID: 38555656 Free article.
Epidemiology and Risk Factors of Mycotic Aneurysm in Patients With Infective Endocarditis and the Impact of its Rupture in Outcomes. Analysis of a National Prospective Cohort.
Calderón-Parra J, Domínguez F, González-Rico C, Arnaiz de Las Revillas F, Goenaga MÁ, Alvarez I, Muñoz P, Alonso D, Rodríguez-García R, Miró JM, De Alarcón A, Antorrena I, Goikoetxea-Agirre J, Moral-Escudero E, Ojeda-Burgos G, Ramos-Martínez A; Spanish Collaboration on Endocarditis (GAMES). Calderón-Parra J, et al. Open Forum Infect Dis. 2024 Mar 13;11(3):ofae121. doi: 10.1093/ofid/ofae121. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38500574 Free PMC article. Clinical Trial.
COVID-19 mortality amongst the immunosuppresed.
Moreno-Torres V, Martínez-Urbistondo M, Calderón-Parra J, de Mendoza C, Soriano V. Moreno-Torres V, et al. Among authors: calderon parra j. J Infect. 2024 Apr;88(4):106137. doi: 10.1016/j.jinf.2024.106137. Epub 2024 Mar 11. J Infect. 2024. PMID: 38479495 Free article. No abstract available.
Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the Omicron era: A prospective cohort study.
Calderón-Parra J, Gutiérrez-Villanueva A, Ronda-Roca G, Jimenez MLM, de la Torre H, Ródenas-Baquero M, Paniura-Pinedo M, Lozano-Llano C, Pintos-Pascual I, Fernández-Cruz A, Ramos-Martínez A, Muñez-Rubio E. Calderón-Parra J, et al. Int J Antimicrob Agents. 2024 Mar;63(3):107095. doi: 10.1016/j.ijantimicag.2024.107095. Epub 2024 Jan 18. Int J Antimicrob Agents. 2024. PMID: 38244814 Free article.
Ceft-to-Ceft Study: Real-Life Experience with Ceftaroline and Ceftobiprole in Treatment of the Principal Infectious Syndromes in a Spanish Multicenter Hospital Cohort.
Arnés García D, Pitto-Robles I, Calderón Parra J, Calvo Salvador M, Herrero Rodríguez C, Gisbert L, Hidalgo-Tenorio C. Arnés García D, et al. Among authors: calderon parra j. Antibiotics (Basel). 2023 Dec 2;12(12):1692. doi: 10.3390/antibiotics12121692. Antibiotics (Basel). 2023. PMID: 38136726 Free PMC article.
Risk of endocarditis among patients with coagulase-negative Staphylococcus bacteremia.
Ramos-Martínez A, González-Merino P, Suanzes-Martín E, la Fuente MM, Escudero-López G, Andrés-Eisenhofer A, Expósito-Palomo E, Gutierrez-Villanueva A, Diego-Yagüe I, Múñez E, Fernandez-Cruz A, Calderón-Parra J. Ramos-Martínez A, et al. Among authors: calderon parra j. Sci Rep. 2023 Sep 20;13(1):15613. doi: 10.1038/s41598-023-41888-7. Sci Rep. 2023. PMID: 37730691 Free PMC article.
Clinical presentation, microbiology, and prognostic factors of prosthetic valve endocarditis. Lessons learned from a large prospective registry.
Ramos-Martínez A, Domínguez F, Muñoz P, Marín M, Pedraz Á, Fariñas MC, Tascón V, de Alarcón A, Rodríguez-García R, Miró JM, Goikoetxea J, Ojeda-Burgos G, Escrihuela-Vidal F, Calderón-Parra J; GAMES investigators. Ramos-Martínez A, et al. Among authors: calderon parra j. PLoS One. 2023 Sep 8;18(9):e0290998. doi: 10.1371/journal.pone.0290998. eCollection 2023. PLoS One. 2023. PMID: 37682961 Free PMC article.
46 results